• Protoporphyrin IX: Bridging Heme Metabolism to Ferroptosis T

  2026-08-06

  This thought-leadership article explores the mechanistic and translational significance of Protoporphyrin IX in heme biosynthesis, iron metabolism, and the design of next-generation photodynamic and ferroptosis-modulating cancer therapies. Drawing on recent advances in hepatocellular carcinoma research, it provides actionable guidance for leveraging high-purity Protoporphyrin IX (APExBIO, SKU B8225) in advanced experimental systems and positions the compound at the intersection of metabolic regulation and oncology innovation.

• Fludarabine: Strategic DNA Synthesis Inhibition in Oncology

  2026-08-05

  Explore how Fludarabine, a purine analog DNA synthesis inhibitor, empowers translational researchers with mechanistic precision and workflow agility in leukemia and multiple myeloma studies. This article blends cutting-edge biological insight with strategic guidance, contextualizing Fludarabine’s role in apoptosis induction, cell cycle arrest, and experimental design—while positioning APExBIO’s rigorously validated reagent at the forefront of hematologic malignancy research.

• Doxorubicin Hydrochloride: Next-Gen Liposomal Research & Ass

  2026-08-05

  Explore advanced applications of doxorubicin hydrochloride in dual-loaded liposome systems, new assay optimization strategies, and breakthroughs in encapsulation efficiency. This article delivers unique insight for cancer chemotherapy research and practical laboratory workflows.

• JNJ-26854165 (Serdemetan): Applied Workflows for p53-Driven

  2026-08-04

  JNJ-26854165 (Serdemetan) is a potent small molecule HDM2 antagonist that enables robust p53 activation, apoptosis induction, and radiosensitization in tumor models. This article delivers experiment-ready protocols, advanced troubleshooting, and actionable guidance to maximize impact in applied cancer research—based on data-driven insights and translational reference frameworks.

• KNUCKLES Integrates Auxin and Cytokinin to Terminate Floral

  2026-08-04

  This study elucidates how the transcriptional repressor KNUCKLES (KNU) orchestrates the timely termination of floral meristems in Arabidopsis by modulating auxin distribution and cytokinin activity through direct epigenetic repression of key regulatory genes. The findings illuminate a molecular network underpinning meristem determinacy, refining developmental models and informing broader research into stem cell niche regulation.

• Reactive Oxygen Species Assay Kit: Precision for Live-Cell R

  2026-08-03

  The APExBIO Reactive Oxygen Species Assay Kit empowers researchers with highly sensitive, reproducible measurement of intracellular ROS using the robust DCFH-DA probe. This article delivers practical workflow guidance, advanced use-case insights, and troubleshooting strategies to elevate oxidative stress assays in cancer and cell signaling research.

• Sinapine Selectively Disrupts Gαq-PLCβ3 Axis in CVD Models

  2026-08-03

  This study identifies sinapine as a novel, EF hand-targeting inhibitor of the Gαq-PLCβ3 protein-protein interaction, significantly alleviating hypertension and aldosteronism in animal models. The work delineates a precise mechanism to modulate RAAS signaling in cardiovascular disease, distinguishing sinapine's selectivity from broader Gαq inhibitors and expanding avenues for targeted PLC inhibition.

• SU 5402: Advanced Workflows for Cancer and Neuronal Research

  2026-08-02

  SU 5402 stands out as a versatile inhibitor for dissecting receptor tyrosine kinase signaling in both cancer and iPSC-derived neuronal models. This article provides actionable workflows, troubleshooting strategies, and critical insights for maximizing the translational impact of SU 5402 in multiple myeloma research and emerging latency models.

• MK-8745: Precision Aurora A Inhibitor for Cancer Workflows

  2026-08-01

  MK-8745 stands out as a potent and selective Aurora A inhibitor, enabling researchers to dissect cell cycle and apoptosis mechanisms in advanced cancer models. Its unique efficacy in p53-dependent contexts and robust performance in tumor xenograft assays offer actionable advantages for translational oncology research.

• PF-573228: Potent FAK Inhibitor for Cell Migration and Angio

  2026-07-31

  PF-573228 is a nanomolar FAK inhibitor that blocks autophosphorylation at FAK Tyr397, disrupting cancer cell migration and angiogenesis. This compound, available from APExBIO, is validated in multiple cell models and supports mechanotransduction research.

• BGJ398 (NVP-BGJ398): Precision FGFR Inhibition for Oncology

  2026-07-31

  BGJ398 (NVP-BGJ398) is a highly selective inhibitor of FGFR1, FGFR2, and FGFR3, validated for use in oncology research and FGFR-driven malignancies studies. Key evidence confirms its potency at nanomolar concentrations, its mechanism of apoptosis induction in cancer cells, and its essential role in FGFR signaling pathway research.

• FGFR1 Regulates Early Adipogenesis in Human Preadipocytes

  2026-07-30

  Widberg et al. (2009) demonstrate that FGFR1 activity is uniquely required for the early proliferation and differentiation of human preadipocytes, distinguishing FGF-1’s role from other growth factors. Their findings establish FGFR1 as a critical regulator of adipogenesis and a potential therapeutic target for obesity intervention.

• Substrate Stiffness Directs Dentinogenesis via LAMB1–FAK–MEK

  2026-07-30

  This study demonstrates that substrate stiffness directly regulates odontoblast-like cell differentiation and dentin matrix formation through a LAMB1–FAK–MEK1/2 signaling pathway. The findings provide mechanistic insight into how mechanical cues at cell–material interfaces can be leveraged in dental tissue engineering and reparative strategies.

• Deep Learning and iPSC-CMs Advance Cardiotoxicity Screening

  2026-07-29

  Grafton et al. present a high-content screening platform that leverages deep learning and iPSC-derived cardiomyocytes to detect drug-induced cardiotoxicity with improved sensitivity. This approach enables early-stage de-risking in drug discovery, holding promise for more efficient and accurate toxicity assessment.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Superior mRNA Delivery Tool

  2026-07-29

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) redefines mRNA delivery workflows with dual fluorescence and immune-evasive chemistry, enabling precise, real-time tracking and robust translation efficiency assays. This APExBIO innovation empowers researchers to optimize nanoparticle formulations, troubleshoot gene delivery, and accelerate functional genomics discovery.

11271 records 1/752 page Next 12345 下5页 Last page